Neumora Therapeutics | IPO Presentation Deck | 32 slides · page 8 of 32
Includes a detailed biological mechanism diagram showing the interaction of KOR, dynorphin, and neurotransmitters.
Pitch deck · solution · present_solution · overcrowded density
Slide locked Sign in to view
Slide schematic 7/7
callout 1/1 image 1/1 list 2/2 paragraph 1/1 title 2/2
Components 7
primary illustration bullet bullet paragraph action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1